Cochrane Abstracts
Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Poly(ADP‐ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438488/all/Poly_ADP‐ribose__polymerase__PARP__inhibitors_for_the_treatment_of_ovarian_cancer. Accessed 29 September 2023.
Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438488/all/Poly_ADP‐ribose__polymerase__PARP__inhibitors_for_the_treatment_of_ovarian_cancer. Accessed September 29, 2023.
Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438488/all/Poly_ADP‐ribose__polymerase__PARP__inhibitors_for_the_treatment_of_ovarian_cancer
Poly(ADP‐ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer [Internet]. In: Cochrane Abstracts. [cited 2023 September 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438488/all/Poly_ADP‐ribose__polymerase__PARP__inhibitors_for_the_treatment_of_ovarian_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer
ID - 438488
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438488/all/Poly_ADP‐ribose__polymerase__PARP__inhibitors_for_the_treatment_of_ovarian_cancer
DB - Evidence Central
DP - Unbound Medicine
ER -
